Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration announced it has approved Abbott Laboratories' companion diagnostic for identifying acute myeloid leukemia patients who have IDH2 gene mutations, and who could benefit from treatment with a new Celgene therapy called Idhifa.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.